Details of the Drug
General Information of Drug (ID: DMTBYCY)
Drug Name |
RX-0201N
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | RX-0201-nano; AKT-1 protein kinase inhibitor (oral nanoliposomal formulation, cancer), Rexahn Pharmaceuticals | ||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||